Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yedidia

Showing results (61-70 of 232) with videos related to

Pageof 24
Sort By:
Phytopathology|October 24, 2008
Involvement of Jasmonic Acid/Ethylene Signaling Pathway in the Systemic Resistance Induced in Cucumber by Trichoderma asperellum T203Michal Shoresh, Iris Yedidia, Ilan Chet
Human & Experimental Toxicology|August 18, 2004
Toxicological features of deliberate self-poisoningsYedidia Bentur, Bianca Raikhlin-Eisenkraft, Michal Lavee
European Journal of Immunology|March 4, 1998
Primary B cells essentially lack constitutive NF-kappa B activityY Yedidia, Y Ben-Neriah, S Jung
Veterinary and Human Toxicology|February 14, 2003
Beneficial late administration of obidoxime in malathion poisoningYedidia Bentur, Bianca Raikhlin-Eisenkraft, Pierre Singer
Basic & Clinical Pharmacology & Toxicology|December 17, 2013
Medication errors outside healthcare facilities: a national poison centre perspectiveOphir Lavon, Adi Ben-Zeev, Yedidia Bentur
Toxicon : Official Journal of the International Society on Toxinology|July 1, 2004
Evaluation of antivenom therapy in Vipera palaestinae bitesYedidia Bentur, Bianca Raikhlin-Eisenkraft, Maya Galperin
Microorganisms|December 23, 2022
Disalicylic Acid Provides Effective Control of <i>Pectobacterium brasiliense</i>Sapir Tuizer, Manoj Pun, Iris Yedidia, et al.
Vaccine|May 30, 2002
Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virusSung Ho Jeon, Tamar Ben-Yedidia, Ruth Arnon
Therapeutic Advances in Vaccines and Immunotherapy|February 17, 2022
Is a universal influenza vaccine feasible?Joshua E Phillipson, Ron Babecoff, Tamar Ben-Yedidia
Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002
Peptide-based synthetic recombinant vaccines with anti-viral efficacyR Arnon, R Tarrab-Hazdai, T Ben-Yedidia
Pageof 24

Showing results (61-70 of 232) with videos related to

Sort By:
Pageof 24
Phytopathology|October 24, 2008
Involvement of Jasmonic Acid/Ethylene Signaling Pathway in the Systemic Resistance Induced in Cucumber by Trichoderma asperellum T203Michal Shoresh, Iris Yedidia, Ilan Chet
Human & Experimental Toxicology|August 18, 2004
Toxicological features of deliberate self-poisoningsYedidia Bentur, Bianca Raikhlin-Eisenkraft, Michal Lavee
European Journal of Immunology|March 4, 1998
Primary B cells essentially lack constitutive NF-kappa B activityY Yedidia, Y Ben-Neriah, S Jung
Veterinary and Human Toxicology|February 14, 2003
Beneficial late administration of obidoxime in malathion poisoningYedidia Bentur, Bianca Raikhlin-Eisenkraft, Pierre Singer
Basic & Clinical Pharmacology & Toxicology|December 17, 2013
Medication errors outside healthcare facilities: a national poison centre perspectiveOphir Lavon, Adi Ben-Zeev, Yedidia Bentur
Toxicon : Official Journal of the International Society on Toxinology|July 1, 2004
Evaluation of antivenom therapy in Vipera palaestinae bitesYedidia Bentur, Bianca Raikhlin-Eisenkraft, Maya Galperin
Microorganisms|December 23, 2022
Disalicylic Acid Provides Effective Control of <i>Pectobacterium brasiliense</i>Sapir Tuizer, Manoj Pun, Iris Yedidia, et al.
Vaccine|May 30, 2002
Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virusSung Ho Jeon, Tamar Ben-Yedidia, Ruth Arnon
Therapeutic Advances in Vaccines and Immunotherapy|February 17, 2022
Is a universal influenza vaccine feasible?Joshua E Phillipson, Ron Babecoff, Tamar Ben-Yedidia
Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002
Peptide-based synthetic recombinant vaccines with anti-viral efficacyR Arnon, R Tarrab-Hazdai, T Ben-Yedidia
Pageof 24